AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
CUTANEOUS MELANOMA METASTASES - REPLY
Authors: PECHERSTORFER M KECK A
Citation: M. Pecherstorfer et A. Keck, CUTANEOUS MELANOMA METASTASES - REPLY, The New England journal of medicine, 338(13), 1998, pp. 923-923
DIAGNOSTIC VALIDITY OF SERUM BONE SIALOPROTEIN IN VERTEBRAL OSTEOPOROSIS AND MULTIPLE-MYELOMA
Authors: SEIBEL MJ WOITGE HW LUDWIG H ZIEGLER R PECHERSTORFER M
Citation: Mj. Seibel et al., DIAGNOSTIC VALIDITY OF SERUM BONE SIALOPROTEIN IN VERTEBRAL OSTEOPOROSIS AND MULTIPLE-MYELOMA, Journal of bone and mineral research, 12, 1997, pp. 623-623
CUTANEOUS MELANOMA METASTASES
Authors: PECHERSTORFER M
Citation: M. Pecherstorfer, CUTANEOUS MELANOMA METASTASES, The New England journal of medicine, 337(20), 1997, pp. 1435-1435
INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IMPROVES THE DETECTION OF MALIGNANT-CELLS IN EFFUSIONS FROM BREAST-CANCER PATIENTS
Authors: ZOJER N FIEGL M ANGERLER J MULLAUER L GSUR A ROKA S PECHERSTORFER M HUBER H DRACH J
Citation: N. Zojer et al., INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IMPROVES THE DETECTION OF MALIGNANT-CELLS IN EFFUSIONS FROM BREAST-CANCER PATIENTS, British Journal of Cancer, 75(3), 1997, pp. 403-407
BONE-RESORPTION IN MULTIPLE-MYELOMA AND IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - QUANTIFICATION BY URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN
Authors: PECHERSTORFER M SEIBEL MJ WOITGE HW HORN E SCHUSTER J NEUDA J SAGASTER P KOHN H BAYER P THIEBAUD D LUDWIG H
Citation: M. Pecherstorfer et al., BONE-RESORPTION IN MULTIPLE-MYELOMA AND IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - QUANTIFICATION BY URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN, Blood, 90(9), 1997, pp. 3743-3750
GLUCOCORTICOIDS DECREASE THE PRODUCTION OF PARATHYROID HORMONE-RELATED PROTEIN IN-VITRO BUT NOT IN-VIVO IN THE WALKER-CARCINOSARCOMA-256 RAT MODEL
Authors: SCHILLING T PECHERSTORFER M BLIND E KOHL B WAGNER H ZIEGLER R RAUE F
Citation: T. Schilling et al., GLUCOCORTICOIDS DECREASE THE PRODUCTION OF PARATHYROID HORMONE-RELATED PROTEIN IN-VITRO BUT NOT IN-VIVO IN THE WALKER-CARCINOSARCOMA-256 RAT MODEL, Bone, 18(4), 1996, pp. 315-319
INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AFTER BISPHOSPHONATES TREATMENT IN-VITRO AND IN PATIENTS WITH MALIGNANCY
Authors: SAUTY A PECHERSTORFER M ZIMMERROTH I FIORONI P JUILLERAT L MARKERT M LUDWIG H LEUENBERGER P BURCKHARDT P THIEBAUD D
Citation: A. Sauty et al., INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AFTER BISPHOSPHONATES TREATMENT IN-VITRO AND IN PATIENTS WITH MALIGNANCY, Bone, 18(2), 1996, pp. 133-139
ADMINISTRATION OF THE BISPHOSPHONATE IBANDRONATE (BM-21.0955) BY INTRAVENOUS BOLUS INJECTION
Authors: PECHERSTORFER M LUDWIG H SCHLOSSER K BUCK S HUSS HJ BODY JJ
Citation: M. Pecherstorfer et al., ADMINISTRATION OF THE BISPHOSPHONATE IBANDRONATE (BM-21.0955) BY INTRAVENOUS BOLUS INJECTION, Journal of bone and mineral research, 11(5), 1996, pp. 587-593
DIAGNOSTIC VALIDITY OF URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN IN MULTIPLE-MYELOMA AND MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE
Authors: SEIBEL MJ WOITGE HW LUDWIG H ZIEGLER R PECHERSTORFER M
Citation: Mj. Seibel et al., DIAGNOSTIC VALIDITY OF URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN IN MULTIPLE-MYELOMA AND MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE, Journal of bone and mineral research, 11, 1996, pp. 734-734
RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY
Authors: PECHERSTORFER M HERRMANN Z BODY JJ MANEGOLD C DEGARDIN M CLEMENS MR THURLIMANN B TUBIANAHULIN M STEINHAUER EU VANEIJKEREN M HUSS HJ THIEBAUD D
Citation: M. Pecherstorfer et al., RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY, Journal of clinical oncology, 14(1), 1996, pp. 268-276
SERUM IMMUNOREACTIVE BONE SIALOPROTEIN AS A NEW MARKER OF BONE TURNOVER IN METABOLIC AND MALIGNANT BONE-DISEASE
Authors: SEIBEL MJ WOITGE HW PECHERSTORFER M KARMATSCHEK M HORN E LUDWIG H ARMBRUSTER FP ZIEGLER R
Citation: Mj. Seibel et al., SERUM IMMUNOREACTIVE BONE SIALOPROTEIN AS A NEW MARKER OF BONE TURNOVER IN METABOLIC AND MALIGNANT BONE-DISEASE, The Journal of clinical endocrinology and metabolism, 81(9), 1996, pp. 3289-3294
PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PRO GNOSIS IN CARCINOMA OF THE BREAST
Authors: MAYERHOFER K STOLZLECHNER J YILDIZ S HAIDER K HEINZL H JAKESZ R PECHERSTORFER M ROSEN H SEVELDA P ZEILLINGER R SPEISER P
Citation: K. Mayerhofer et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PRO GNOSIS IN CARCINOMA OF THE BREAST, Geburtshilfe und Frauenheilkunde, 56(1), 1996, pp. 23-27
ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS
Authors: LUDWIG H FRITZ E LEITGEB C PECHERSTORFER M SAMONIGG H SCHUSTER J
Citation: H. Ludwig et al., ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS, European journal of cancer, 31A, 1995, pp. 7-7
PROSPECTIVE RANDOMIZED TRIAL OF DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN PATIENTS WITH MULTIPLE-MYELOMA REQUIRING TREATMENT - A MULTICENTER STUDY
Authors: HEIM ME CLEMENS MR QUEISSER W PECHERSTORFER M BOEWER C HEROLD M FRANKE A HERRMANN Z LOOSE R EDLER L
Citation: Me. Heim et al., PROSPECTIVE RANDOMIZED TRIAL OF DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN PATIENTS WITH MULTIPLE-MYELOMA REQUIRING TREATMENT - A MULTICENTER STUDY, Onkologie, 18(5), 1995, pp. 439-448
5-FLUOROURACIL AND FOLINIC ACID WITH OR W ITHOUT ALPHA-2C INTERFERON IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - PRELIMINARY-RESULTSOF A MULTICENTER PROSPECTIVE RANDOMIZED PHASE-III TRIAL
Authors: MOSER R HAUSMANINGER H LUDWIG H FRIDRIK M SCHMIDT H MLINERITSCH B PECHERSTORFER M MICHLMAYR G KOPF C SAMONIGG H
Citation: R. Moser et al., 5-FLUOROURACIL AND FOLINIC ACID WITH OR W ITHOUT ALPHA-2C INTERFERON IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - PRELIMINARY-RESULTSOF A MULTICENTER PROSPECTIVE RANDOMIZED PHASE-III TRIAL, Onkologie, 18(2), 1995, pp. 131-135
THE BISPHOSPHONATE DILEMMA - REPLY
Authors: PECHERSTORFER M
Citation: M. Pecherstorfer, THE BISPHOSPHONATE DILEMMA - REPLY, The Journal of nuclear medicine, 36(4), 1995, pp. 705-706
THE DIAGNOSTIC-VALUE OF URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN, SERUM TOTAL ALKALINE-PHOSPHATASE, AND URINARY CALCIUM EXCRETION IN NEOPLASTIC BONE-DISEASE
Authors: PECHERSTORFER M ZIMMERROTH I SCHILLING T WOITGE HW SCHMIDT H BAUMGARTNER G THIEBAUD D LUDWIG H SEIBEL MJ
Citation: M. Pecherstorfer et al., THE DIAGNOSTIC-VALUE OF URINARY PYRIDINIUM CROSS-LINKS OF COLLAGEN, SERUM TOTAL ALKALINE-PHOSPHATASE, AND URINARY CALCIUM EXCRETION IN NEOPLASTIC BONE-DISEASE, The Journal of clinical endocrinology and metabolism, 80(1), 1995, pp. 97-103
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY
Authors: LUDWIG H SUNDAL E PECHERSTORFER M LEITGEB C BAUERNHOFER T BEINHAUER A SAMONIGG H KAPPELER AW FRITZ E
Citation: H. Ludwig et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY, Cancer, 76(11), 1995, pp. 2319-2329
HIGH-DOSE INTRAVENOUS MELPHALAN IN A PATIENT WITH MULTIPLE-MYELOMA AND OLIGURIC RENAL-FAILURE
Authors: PECHERSTORFER M ZIMMERROTH I WEIDINGER S IRSIGLER K HALBMAYER WM ULRICH W FISCHER M BAUMGARTNER G
Citation: M. Pecherstorfer et al., HIGH-DOSE INTRAVENOUS MELPHALAN IN A PATIENT WITH MULTIPLE-MYELOMA AND OLIGURIC RENAL-FAILURE, The Clinical investigator, 72(7), 1994, pp. 522-525
PS2 PROTEIN STATUS FAILS TO BE AN INDEPENDENT PROGNOSTIC FACTOR IN ANAVERAGE BREAST-CANCER POPULATION
Authors: SPEISER P STOLZLECHNER J HAIDER K HEINZL H JAKESZ R PECHERSTORFER M ROSEN H SEVELDA P ZEILLIGER R
Citation: P. Speiser et al., PS2 PROTEIN STATUS FAILS TO BE AN INDEPENDENT PROGNOSTIC FACTOR IN ANAVERAGE BREAST-CANCER POPULATION, Anticancer research, 14(5B), 1994, pp. 2125-2130
PARATHYROID HORMONE-RELATED PROTEIN AND LIFE EXPECTANCY IN HYPERCALCEMIC CANCER-PATIENTS
Authors: PECHERSTORFER M SCHILLING T BLIND E ZIMMERROTH I BAUMGARTNER G ZIEGLER R RAUE F
Citation: M. Pecherstorfer et al., PARATHYROID HORMONE-RELATED PROTEIN AND LIFE EXPECTANCY IN HYPERCALCEMIC CANCER-PATIENTS, The Journal of clinical endocrinology and metabolism, 78(5), 1994, pp. 1268-1270
QUALITY-OF-LIFE IN CHRONIC ANEMIA OF CANCER DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
Authors: LEITGEB C PECHERSTORFER M FRITZ E LUDWIG H
Citation: C. Leitgeb et al., QUALITY-OF-LIFE IN CHRONIC ANEMIA OF CANCER DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Cancer, 73(10), 1994, pp. 2535-2542
PREDICTION OF RESPONSE TO ERYTHROPOIETIN TREATMENT IN CHRONIC ANEMIA OF CANCER
Authors: LUDWIG H FRITZ E LEITGEB C PECHERSTORFER M SAMONIGG H SCHUSTER J
Citation: H. Ludwig et al., PREDICTION OF RESPONSE TO ERYTHROPOIETIN TREATMENT IN CHRONIC ANEMIA OF CANCER, Blood, 84(4), 1994, pp. 1056-1063
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF CHRONIC ANEMIA IN MULTIPLE-MYELOMA AND SQUAMOUS-CELL CARCINOMA
Authors: LUDWIG H PECHERSTORFER M LEITGEB C FRITZ E
Citation: H. Ludwig et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF CHRONIC ANEMIA IN MULTIPLE-MYELOMA AND SQUAMOUS-CELL CARCINOMA, Stem cells, 11(5), 1993, pp. 348-355
RELATIONSHIPS BETWEEN PLASMA CALCIUM, PTH AND PTHRP AFTER BISPHOSPHONATES TREATMENT OF MALIGNANT HYPERCALCEMIA - EVIDENCE OF AN INFLUENCE OF CALCIUM ON PTHRP
Authors: THIEBAUD D PECHERSTORFER M BUCLIN T JACQUET AF BURCKHARDT P
Citation: D. Thiebaud et al., RELATIONSHIPS BETWEEN PLASMA CALCIUM, PTH AND PTHRP AFTER BISPHOSPHONATES TREATMENT OF MALIGNANT HYPERCALCEMIA - EVIDENCE OF AN INFLUENCE OF CALCIUM ON PTHRP, Journal of bone and mineral research, 8, 1993, pp. 190000201-190000201
Risultati: 1-25 | 26-27